Clinical trials: Clinical Documentation
Clinical Documentation
Notation Optimization Through Template Engineering
This is a randomized non-blinded controlled trial of a standard note template versus a redesigned note template using a simulated patient encounter and the electronic medical record.
- Trial name
- NOTE (NCT04333238)
- Testing
- New progress note template, Standard progress note template
- Where
- United States
- Volunteers
- 36 people, healthy volunteers welcome
- Sponsor
- Johns Hopkins University
Primary Immunodeficiencies (PID)
Retrospective, Observational Chart Review Study Conducted in Poland to Document the Management and Clinical Outcome of CUVITRU and HYQVIA in Pediatric Participants (< 18 Years) With Primary Immunodeficiency (PID)
The purpose of this observational, multi-center, retrospective cohort study is to assess treatment patterns of Cuvitru (SCIG) 20 percent (%) and HyQvia (fSCIG) in polish pediatric participants with PID.
- Trial name
- IG-TATRY (NCT04636502)
- Where
- 5 sites in Poland
- Volunteers
- 96 people
- Sponsor
- Shire
Clinical Decision-making, Medical Reporting
Artificial Intelligence as a Decision Making Tool in Emergency Department
This study will evaluate the performance of a large language model (LLM)-based clinical decision support system in the emergency department at Rambam Health Care Campus.
- Conditions
- Clinical Decision-making, Medical Reporting, Emergency Department Visit, Information Systems
- Trial name
- NCT06902675
- Where
- Israel
- Volunteers
- 100,000 people
- Sponsor
- Rambam Health Care Campus
AI-assisted Documentation
AI-Assisted Clinical Documentation in Nurse-Led Telehealth Contacts
Background: No randomized controlled trial evidence currently exists on the effectiveness of ambient artificial intelligence (AI)-assisted clinical documentation.
- Trial name
- NCT07750600
- Testing
- AI-assisted clinical documentation (ambient AI scribe, Tandem Health)
- Where
- Finland
- Volunteers
- 64 people, healthy volunteers welcome
- Sponsor
- Hospital District of Helsinki and Uusimaa
Post Stroke Arm Spasticity
Study to Document the Effectiveness of Dysport in Patients Suffering From Upper Limb Spasticity (ULS) After Stroke
The objective of this non-interventional study is to evaluate clinical effectiveness and cost effectiveness of Dysport within the reimbursement scheme called "drug programme" funded by Polish National Health Fund (NHF) for…
- Trial name
- PSAS REGISTRY (NCT02444494)
- Where
- 6 sites in Poland
- Volunteers
- 108 people
- Sponsor
- Ipsen
Ankylosing Spondylitis
Basic Documentation of Adalimumab (Humira) in Patients With Ankylosing Spondylitis (AS)
The research question explored in this study was whether the effectiveness and safety of adalimumab in participants with ankylosing spondylitis was maintained during long-term therapy in routine clinical practice in Germany.
- Trial name
- NCT01079182
- Volunteers
- 4,681 people
- Sponsor
- AbbVie (prior sponsor, Abbott)
Burnout, Professionals, Medical Records Systems, Computerized
Ambient AI Scribe (Voa Health) in Outpatient Clinics: Draft Notes, Documentation Burden, and Well-Being
The goal of this randomized clinical trial is to learn whether an "ambient AI scribe" (Voa Health) can reduce documentation burden and improve physician well-being and patient experience in outpatient clinics.
- Conditions
- Burnout, Professionals, Medical Records Systems, Computerized, Physician-Patient Relations, Ambulatory Care
- Trial name
- SOAR (NCT07302906)
- Testing
- Ambient AI scribe for clinical documentation (Voa Health), Usual documentation without AI scribe (standard care)
- Where
- Brazil
- Volunteers
- 300 people
- Sponsor
- Pedro Angelo Basei de Paula
Chronic Pain
A 15-day Study to Assess the Safety and Clinical Utility of Duragesic (Fentanyl Transdermal Patch) in the Treatment of Children With Continuous Pain Requiring Narcotic Pain Relief Therapy
The objective of this study is to assess the safety and clinical utility of Duragesic® 12.5 micrograms/hour (a transdermal patch delivering the narcotic pain-reliever fentanyl) in the treatment of children ages 2 to 12 with…
- Trial name
- NCT00271414
- Testing
- Duragesic® (fentanyl) Transdermal Therapeutic System (TTS)
- Volunteers
- 53 people
- Sponsor
- Janssen Pharmaceutica N.V., Belgium
Moderate to Severe Plaque Psoriasis
Documentation of Humira in Psoriasis Patients in Routine Clinical Practice
Safety and Effectiveness of adalimumab (Humira) in Psoriasis Patients in Routine Clinical Practice.
- Trial name
- LOTOS (NCT01077232)
- Where
- 641 sites in Germany
- Volunteers
- 5,442 people
- Sponsor
- AbbVie (prior sponsor, Abbott)
Inpatient Internal Medicine Patients, Patient Discharge
A Pragmatic Trial of AI-Assisted Discharge Summary Generation
The goal of this study is to learn whether an artificial intelligence (AI) tool built into the electronic health record helps hospital physicians write discharge summaries.
- Conditions
- Inpatient Internal Medicine Patients, Patient Discharge, Documentation, Artificial Intelligence (AI)
- Trial name
- DRAFT-AI (NCT07866001)
- Testing
- Epic Discharge Summary Hospital Course Generator
- Volunteers
- 80 people
- Sponsor
- Unity Health Toronto
Anemia
An Observational Study of Mircera (Methoxy Polyethylene Glycol-epoetin Beta) in Anemic Patients With Chronic Kidney Disease (NORM)
This observational, prospective, multi-centre, single-arm study will evaluate the efficacy of Mircera (methoxy polyethylene glycol-epoetin beta) in patients with chronic kidney disease previously on treatment with short-acting…
- Trial name
- NCT01417377
- Testing
- Mircera
- Where
- 6 sites in Pakistan
- Volunteers
- 22 people
- Sponsor
- Hoffmann-La Roche
D010051, Ovarian Cancer
Validation of ESGO Quality Indicators in Advanced Ovarian Cancer Surgery
This study, organized by the European Society of Gynaecological Oncology (ESGO), evaluates the clinical impact of adherence to ten ESGO-established quality indicators (QIs) in advanced ovarian cancer surgery.
- Conditions
- D010051, Ovarian Cancer, Advanced-stage Ovarian Cancer, FIGO Stages III and IV
- Trial name
- retroESGO ov1 (NCT07567573)
- Testing
- Preoperative Evaluations, Cytoreductive Surgery, Perioperative Management
- Where
- Belgium
- Volunteers
- 11,383 people
- Sponsor
- European Society of Gynaecological Oncology
Effectiveness of AI-assisted Clinical Documentation Tool, Healthy
Effectiveness of AI-Assisted Clinical Documentation
Effectiveness of AI-assisted clinical documentation tool (AI scribes) in healthcare services using staggered difference-in-differences and multiple sources of data including registers, questionnaires and interviews.
- Trial name
- NCT07742618
- Testing
- AI clinical documentation tool
- Where
- Finland
- Volunteers
- 400 people, healthy volunteers welcome
- Sponsor
- University of Turku
Pediatric Solid Tumors
A Study to Document Long-Term Safety and Continued Benefit of Irinotecan and Carboplatin or Irinotecan in Subjects With Refractory Solid Tumors (Rollover Study -001, -002)
The purpose of this study is to determine the long term safety of patients with refractory solid tumors who have experienced clinical benefit after at least 6 cycles of treatment in BMS Protocol CA124-001 or CA124-002.
- Trial name
- NCT00990912
- Testing
- Carboplatin, Irinotecan
- Volunteers
- 20 people
- Sponsor
- Bristol-Myers Squibb
Autism Spectrum Disorder (ASD), Central Auditory Processing Disorder
Mental And Speech Developmental Delay Autism Spectrum-Type Behavioral Disorder
FAMILY SYSTEM CITADEL 2060.METHODOLOGY "VOICE OF SLEEP MAMABEE 2026-2085 Systemic work with brain neurons through training modules at the border of sleep in clinical, psychological and strategic logic.
- Conditions
- Autism Spectrum Disorder (ASD), Central Auditory Processing Disorder, Nervous System Disorder, Neurological Disorder
- Trial name
- NCT07670000
- Testing
- Audio fairy tales
- Where
- United States
- Volunteers
- 1 people
- Sponsor
- Natalia Poluektova
Psoriatic Arthritis
Safety and Effectiveness and Effect on Quality of Life and Work Productivity of Humira in Patients With Psoriatic Arthritis in Clinical Routine
Safety and effectiveness, quality of life and work productivity of Humira in patients with psoriatic arthritis in clinical routine.
- Trial name
- ELAN (NCT01078610)
- Testing
- adalimumab (Humira)
- Sponsor
- Abbott
Logoneurosis
Logoneurosis. Complete Remission. Clinical Document No. 001. Family System CITADEL 2060: METHODOLOGY "VOICE OF SLEEP MAMABEE 2026-2085"
Training Modules: Three fairy tales Doctrine "Voice of Sleep: MамаBee 2026-2085" Family System: "Citadel 2060" Systemic work with brain neurons through training modules at the border of sleep in clinical, psychological and…
- Trial name
- MamaBee (NCT07628114)
- Testing
- Voice of Sleep MamaBee 2026-2085 Training Modules: Systemic work with brain neurons through training modules at the border of sleep. Restoration of the nervous system core in real time.
- Where
- United States
- Volunteers
- 1 people
- Sponsor
- Pisareva Citadel Group LLC
Clinical Documentation, Artificial Intelligence
Ambient Audio-Visual Capture for Clinical Documentation and Assessment
AI-powered tools that automatically document clinical conversations are being adopted rapidly in outpatient settings but have not been evaluated in hospital wards.
- Conditions
- Clinical Documentation, Artificial Intelligence, Surgical Education, Medical Education
- Trial name
- BLACKFRAME-AV- (NCT07649772)
- Testing
- BlackFrame ambient audio-visual capture platform
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- BlackFrame.ai
Healthy
Modified Consent Form Utility
Subjects enrolling into a nutrition study of the effects of tea on fat absorption will be randomized to receive either a standard informed consent document or a modified document that is shorter and more easily understood than…
- Trial name
- NCT00715923
- Testing
- Modified consent form, Standard consent form
- Where
- United States
- Volunteers
- 30 people, healthy volunteers welcome
- Sponsor
- University of California, Davis
Autoimmune Diseases
Documentation of the Safety and Effectiveness Profile of the IgG Immunoadsorber GLOBAFFIN® in Clinical Routine
Documentation of the safety and effectiveness profile of the CE-labelled immunoadsorber GLOBAFFIN® in clinical routine according to their intended use.
- Trial name
- SEPIAR (NCT04078698)
- Testing
- Immunoadsorber GLOBAFFIN®
- Where
- 3 sites in Germany
- Volunteers
- 34 people
- Sponsor
- Fresenius Medical Care Deutschland GmbH